The DOI matches its Crossref record; 72 of the 72 references it cites were found in a registry or an index.
Oxidative and endoplasmic reticulum stress interplay in sporadic amyotrophic lateral sclerosis
Abstract
The occurrence of endoplasmic reticulum (ER) stress in the sporadic form of amyotrophic lateral sclerosis (ALS) is unknown, despite it has been recently documented in experimental models of the familial form. Here we show that spinal cord from patients with sporadic ALS showed signs of ER stress, such as increased levels of ER chaperones such as protein-disulfide isomerase, and increased phosphorylation of eukaryotic initiation factor 2alpha (eIF2alpha). Among the potential causes of such ER stress proteasomal impairment was confirmed in the same samples by demonstrating increased ubiquitin immunoreactivity and increased protein lipoxidative (125%), glycoxidative (55%) and direct oxidative damage (62%) over control values, as evidenced by mass-spectrometry and immunological methods. We found that protein oxidative damage was strongly associated to ALS-specific changes in fatty acid concentrations, specifically of n-3 series (as docosahexaenoic acid), and in the amount of mitochondrial components as respiratory complexes I and III, suggesting a mitochondrial dysfunction leading to increased free radical production. Oxidative stress was also evidenced in frontal cortex, suggesting that this region is affected early in ALS. As those events were partially reproduced by threohydroxyaspartate exposure in organotypic spinal cord cultures, we concluded that changes in fatty acid composition, mitochondrial function and proteasome activity, which may be driven by excitotoxicity, lead to oxidative stress and finally contribute to ER stress in sporadic ALS.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Additionally, spinal cord segments from autopsy of patients with sporadic ALS show ER stress resulting in the induction of UPR, chaperones, and apoptotic markers [400,401].”
From GANAB and N-Glycans Substrates Are Relevant in Human Physiology, Polycystic Pathology and Multiple Sclerosis: A Review (2022) · cites this paper as [401]
In the citing paper
“Markers of oxidative stress, ER stress, and the UPR are upregulated in spinal cords and anterior horn cells from human patients with sALS [277–280].”
From Autophagy and ALS: mechanistic insights and therapeutic implications (2022) · cites this paper as [280]
Citations
Cites
1 retracted
Atkin, J. D., Farg, M. A., Turner, B. J., Tomas, D., Lysaght, J. A., Nunan, J., Rembach, A., Nagley, P., Beart, P. M., Cheema, S. S., et al. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m603393200 · Cited by 289
RetractedProduction of Reactive Oxygen Species by Mitochondria
Chen, Q., Vazquez, E. J., Moghaddas, S., Hoppel, C. L., & Lesnefsky, E. J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m304854200 · Cited by 1,616
ALS: A Disease of Motor Neurons and Their Nonneuronal Neighbors
Boillée, S., Velde, C. V., & Cleveland, D. W. (2006) · Neuron · doi:10.1016/j.neuron.2006.09.018 · Cited by 1,476
Proteasome inhibitors induce a terminal unfolded protein response in multiple myeloma cells
Obeng, E. A., Carlson, L. M., Gutman, D. M., Harrington, W. J., Lee, K. P., & Boise, L. (2006) · Blood · doi:10.1182/blood-2005-08-3531 · Cited by 1,176
Hong, S., Gronert, K., Devchand, P. R., Moussignac, R.-L., & Serhan, C. N. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300218200 · Cited by 1,000
Endoplasmic Reticulum Stress Signaling in Disease
Marciniak, S. J., & Ron, D. (2006) · Physiological Reviews · doi:10.1152/physrev.00015.2006 · Cited by 951
ER stress and neurodegenerative diseases
Lindholm, D., Wootz, H., & Korhonen, L. (2006) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401778 · Cited by 882
Evidence of Increased Oxidative Damage in Both Sporadic and Familial Amyotrophic Lateral Sclerosis
Ferrante, R. J., Browne, S. E., Shinobu, L. A., Bowling, A. C., Baik, M. J., MacGarvey, U. M., Kowall, N. W., Brown, R. H., & Beal, M. F. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.69052064.x · Cited by 808
Mitochondrial α-Ketoglutarate Dehydrogenase Complex Generates Reactive Oxygen Species
Starkov, A. A., Fiskum, G. M., Chinopoulos, C., Lorenzo, B. J., Browne, S. E., Patel, M. S., & Beal, M. F. (2004) · Journal of Neuroscience · doi:10.1523/jneurosci.1899-04.2004 · Cited by 711
Grune, T., Jung, T., Merker, K., & Davies, K. J. A. (2004) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2004.04.020 · Cited by 666
Cited by
Sorted by citations
Items 101–200 of 357
Cryptic exon splicing function of TARDBP interacts with autophagy in nervous tissue
Torres, P., Ramírez‐Núñez, O., Romero‐Guevara, R., Barés, G., Granado‐Serrano, A. B., Ayala, V., Boada, J., Fontdevila, L., Povedano, M., Sanchı́s, D., et al. (2018) · Autophagy · doi:10.1080/15548627.2018.1474311 · Cited by 77
Self-citationChen, D., Wang, Y., & Chin, E. R. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00170 · Cited by 67
Marco, G. D., Lupino, E., Calvo, A., Moglia, C., Buccinnà, B., Grifoni, S., Ramondetti, C., Lomartire, A., RINAUDO, M. T., Piccinini, M., et al. (2010) · Acta Neuropathologica · doi:10.1007/s00401-010-0786-7 · Cited by 68
Cozzolino, M., Pesaresi, M. G., Gerbino, V., Großkreutz, J., & Carrı̀, M. T. (2012) · Antioxidants and Redox Signaling · doi:10.1089/ars.2011.4328 · Cited by 66
Véjux, A., Namsi, A., Nury, T., Moreau, T., & Lizard, G. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00012 · Cited by 65
Mitochondria-targeted Antioxidants as a Prospective Therapeutic Strategy for Multiple Sclerosis
Fetisova, E. K., Chernyak, B. V., Korshunova, G. A., Muntyan, M. S., & Skulachev, V. P. (2017) · Current Medicinal Chemistry · doi:10.2174/0929867324666170316114452 · Cited by 64
Halloran, M. A., Parakh, S., & Atkin, J. D. (2013) · International Journal of Cell Biology · doi:10.1155/2013/797914 · Cited by 65
Caspase-4 mediates cytoplasmic accumulation of TDP-43 in the primate brains
Yin, P., Guo, X., Yang, W., Yan, S., Yang, S., Zhao, T., Sun, Q., Liu, Y., Li, S., & Li, X. (2019) · Acta Neuropathologica · doi:10.1007/s00401-019-01979-0 · Cited by 65
Calcium-dependent protein folding in amyotrophic lateral sclerosis
Prell, T., Lautenschläger, J., & Großkreutz, J. (2013) · Cell Calcium · doi:10.1016/j.ceca.2013.05.007 · Cited by 63
Kim, S., Kim, D. K., Jeong, S., & Lee, J. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23115894 · Cited by 71
Deciphering lipid dysregulation in ALS: from mechanisms to translational medicine
Agrawal, I., Lim, Y. S., Ng, S., & Ling, S. (2022) · Translational Neurodegeneration · doi:10.1186/s40035-022-00322-0 · Cited by 65
Mir, M., Asensio, V. J., Tolosa, L., Gou-Fàbregas, M., Soler, R. M., Lladó, J., & Olmos, G. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2009.05.049 · Cited by 62
Lipotoxicity of Palmitic Acid on Neural Progenitor Cells and Hippocampal Neurogenesis
Park, H. R., Kim, J., Park, K.-Y., & Lee, J. (2011) · Toxicological Research · doi:10.5487/tr.2011.27.2.103 · Cited by 64
Langou, K., Moumen, A., Pellegrino, C., Aebischer, J., Medina, I., Aebischer, P., & Raoul, C. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.06806.x · Cited by 64
New Advances in the Pharmacology and Toxicology of Lithium: A Neurobiologically Oriented Overview
Bortolozzi, A. A., Fico, G., Berk, M., Solmi, M., Fornaro, M., Quevedo, J., Zarate, C. A., Kessing, L. V., Vieta, E., & Carvalho, A. F. (2024) · Pharmacological Reviews · doi:10.1124/pharmrev.120.000007 · Cited by 68
Catalytic Antioxidants and Neurodegeneration
Golden, T. R., & Patel, M. (2008) · Antioxidants and Redox Signaling · doi:10.1089/ars.2008.2256 · Cited by 62
Mao, D., Lin, G., Tepe, B., Zuo, Z., Tan, K. L., Şentürk, M., Zhang, S., Arenkiel, B. R., Sardiello, M., & Bellen, H. J. (2019) · Autophagy · doi:10.1080/15548627.2019.1580103 · Cited by 59
The unfolded protein response in amyotrophic later sclerosis: results of a phase 2 trial
Dalla Bella, E., Bersano, E., Antonini, G., Borghero, G., Capasso, M., Caponnetto, C., Chiò, A., Corbo, M., Filosto, M., Giannini, F., et al. (2021) · Brain · doi:10.1093/brain/awab167 · Cited by 59
Tagashira, H., Shinoda, Y., Shioda, N., & Fukunaga, K. (2014) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2014.08.012 · Cited by 58
Zatyka, M., Xavier, G. D. S., Bellomo, E. A., Leadbeater, W. E., Astuti, D., Smith, J. C., Michelangeli, F., Rutter, G. A., & Barrett, T. G. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu499 · Cited by 59
Proteostasis disturbance in amyotrophic lateral sclerosis
Medinas, D. B., Valenzuela, V., & Hetz, C. A. (2017) · Human Molecular Genetics · doi:10.1093/hmg/ddx274 · Cited by 67
Amyotrophic lateral sclerosis pathogenesis: a journey through the secretory pathway
Nassif, M., Matus, S., Castillo, K., & Hetz, C. (2010) · Antioxidants & Redox Signaling · doi:10.1089/ars.2009.2991 · Cited by 60
Shimazawa, M., Tanaka, H., Ito, Y., Morimoto, N., Tsuruma, K., Kadokura, M., Tamura, S., Inoue, T., Yamada, M., Takahashi, H., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0015307 · Cited by 58
The integrated stress response in neurodegenerative diseases
Bravo-Jimenez, M. A., Sharma, S., & Karimi‐Abdolrezaee, S. (2025) · Molecular Neurodegeneration · doi:10.1186/s13024-025-00811-6 · Cited by 67
Vitamin D as a Potential Therapy in Amyotrophic Lateral Sclerosis
Gianforcaro, A., & Hamadeh, M. J. (2014) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12204 · Cited by 61
Bose, S., & Cho, J. (2016) · Ageing Research Reviews · doi:10.1016/j.arr.2016.09.004 · Cited by 56
Gentile, F., Doneddu, P. E., Riva, N., Nobile‐Orazio, E., & Quattrini, A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21207471 · Cited by 58
Tracey, T. J., Kirk, S. E., Steyn, F. J., & Ngo, S. T. (2020) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2020.08.012 · Cited by 59
Neuromuscular Junction Protection for the Potential Treatment of Amyotrophic Lateral Sclerosis
Krakora, D., Macrander, C., & Suzuki, M. (2012) · Neurology Research International · doi:10.1155/2012/379657 · Cited by 55
Crosstalk between Endoplasmic Reticulum Stress and Protein Misfolding in Neurodegenerative Diseases
Pereira, C. (2013) · ISRN Cell Biology · doi:10.1155/2013/256404 · Cited by 56
Ruegsegger, C., Maharjan, N., Goswami, A., de L’Etang, A. F., Weis, J., Troost, D., Heller, M., Gut, H., & Saxena, S. (2015) · Acta Neuropathologica · doi:10.1007/s00401-015-1510-4 · Cited by 55
Wang, X., Zhou, S. Y., Ding, X., Ma, M., Zhang, J., Zhou, Y., Wu, E., & Teng, J. (2015) · International Journal of Biological Sciences · doi:10.7150/ijbs.12657 · Cited by 59
Nuclear Receptors as Therapeutic Targets for Neurodegenerative Diseases: Lost in Translation
Moutinho, M., Codocedo, J. F., Puntambekar, S. S., & Landreth, G. E. (2018) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010818-021807 · Cited by 57
Functional Role of the Disulfide Isomerase ERp57 in Axonal Regeneration
Castillo, V., Oñate, M., Woehlbier, U., Rozas, P., Andreu, C. I., Medinas, D. B., Valdés, P., Osorio, F., Mercado, G., Vidal, R. L., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0136620 · Cited by 54
Therrien, M., & Parker, J. A. (2014) · Frontiers in Genetics · doi:10.3389/fgene.2014.00085 · Cited by 64
Mutihac, R., Alegre‐Abarrategui, J., Gordon, D., Farrimond, L. E., Yamasaki-Mann, M., Talbot, K., & Wade‐Martins, R. (2014) · Neurobiology of Disease · doi:10.1016/j.nbd.2014.12.010 · Cited by 55
Yagi, T., Ito, D., Nihei, Y., Ishihara, T., & Suzuki, N. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr304 · Cited by 54
Antioxidant and neuroprotective actions of resveratrol in cerebrovascular diseases
Wang, Q., Yu, Q., & Wu, M. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.948889 · Cited by 58
Martínez, A., Carmona, M., Portero‐Otín, M., Naudí, A., Pamplona, R., & Ferrer, I. (2008) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e31818e06f3 · Cited by 53
Self-citationCacabelos, D., Ramírez‐Núñez, O., Granado‐Serrano, A. B., Torres, P., Ayala, V., Moiseeva, V., Povedano, M., Ferrer, I., Pamplona, R., Portero‐Otín, M., et al. (2016) · Acta Neuropathologica Communications · doi:10.1186/s40478-015-0271-6 · Cited by 51
Self-citationSinha, P., Verma, B., & Ganesh, S. (2020) · Molecular Neurobiology · doi:10.1007/s12035-020-02170-3 · Cited by 52
Emerging drugs for amyotrophic lateral sclerosis
Habib, A. A., & Mitsumoto, H. (2011) · Expert Opinion on Emerging Drugs · doi:10.1517/14728214.2011.604312 · Cited by 52
Dong, X., Wang, Y. R., Qin, S., Liang, Z., Liu, B., Qin, Z., & Wang, Y. (2012) · Neuroscience · doi:10.1016/j.neuroscience.2012.01.018 · Cited by 51
Kwok, C. T., Morris, A. G., Frampton, J., Smith, B. N., Shaw, C. E., & de Belleroche, J. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.01.001 · Cited by 50
Brain Ceramide Metabolism in the Control of Energy Balance
Cruciani‐Guglielmacci, C., López, M., Campaña, M. B., & Stunff, H. L. (2017) · Frontiers in Physiology · doi:10.3389/fphys.2017.00787 · Cited by 52
Metabolomics Biomarkers: A Strategy Toward Therapeutics Improvement in ALS
Lanznaster, D., de Assis, D. R., Corcia, P., Pradat, P., & Blasco, H. (2018) · Frontiers in Neurology · doi:10.3389/fneur.2018.01126 · Cited by 50
Environmental insults: critical triggers for amyotrophic lateral sclerosis
Yu, B., & Pamphlett, R. (2017) · Translational Neurodegeneration · doi:10.1186/s40035-017-0087-3 · Cited by 50
Funikov, S. Y., Rezvykh, A. P., Mazin, P., Morozov, A. V., Maltsev, A. V., Chicheva, M. M., Vikhareva, E. A., Евгеньев, М. Б., & Ustyugov, A. A. (2018) · Neurogenetics · doi:10.1007/s10048-018-0553-9 · Cited by 53
Differential Activation of the ER Stress Factor XBP1 by Oligomeric Assemblies
Castillo‐Carranza, D. L., Zhang, Y., Guerrero‐Munoz, M. J., Kayed, R., Rincón-Limas, D. E., & Fernández-Fúnez, P. (2012) · Neurochemical Research · doi:10.1007/s11064-012-0780-7 · Cited by 51
The unfolded protein response in models of human mutant G93A amyotrophic lateral sclerosis
Prell, T., Lautenschläger, J., Witte, O. W., Carrı̀, M. T., & Großkreutz, J. (2012) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2012.08008.x · Cited by 50
Ayaki, T., Ito, H., Fukushima, H., Inoue, T., Kondo, T., Ikemoto, A., Asano, T., Shodai, A., Fujita, T., Fukui, S., et al. (2014) · Acta Neuropathologica Communications · doi:10.1186/s40478-014-0172-0 · Cited by 47
García-González, P. A., Cabral‐Miranda, F., Hetz, C. A., & Osorio, F. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02541 · Cited by 46
Steinacker, P., Fang, L., Kühle, J., Petzold, A., Tumani, H., Ludolph, A. C., Otto, M., & Brettschneider, J. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023600 · Cited by 44
NRF2 as a therapeutic opportunity to impact in the molecular roadmap of ALS
Jiménez-Villegas, J., Ferraiuolo, L., Mead, R. J., Shaw, P. J., Cuadrado, A., & Rojo, A. I. (2021) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2021.07.022 · Cited by 44
Polycystic Ovary Syndrome: Impact of Lipotoxicity on Metabolic and Reproductive Health
Brennan, K. M., Kroener, L. L., Chazenbalk, G. D., & Dumesic, D. A. (2019) · Obstetrical & Gynecological Survey · doi:10.1097/ogx.0000000000000661 · Cited by 44
Phospholipases in neuronal function: A role in learning and memory?
Joensuu, M., Wallis, T. P., Saber, S. H., & Meunier, F. A. (2019) · Journal of Neurochemistry · doi:10.1111/jnc.14918 · Cited by 47
Translational control by eIF2α in neurons: Beyond the stress response
Bellato, H. M., & Hajj, G. N. M. (2016) · Cytoskeleton · doi:10.1002/cm.21294 · Cited by 46
The ER proteostasis network in ALS: Determining the differential motoneuron vulnerability
Rozas, P., Bargsted, L., Martínez, F., Hetz, C. A., & Medinas, D. B. (2016) · Neuroscience Letters · doi:10.1016/j.neulet.2016.04.066 · Cited by 45
The unfolded protein response is activated in the olfactory system in Alzheimer’s disease
Murray, H. C., Dieriks, B. V., Swanson, M. E. V., Anekal, P. V., Turner, C. P., Faull, R. L. M., Belluscio, L., Koretsky, A. P., & Curtis, M. A. (2020) · Acta Neuropathologica Communications · doi:10.1186/s40478-020-00986-7 · Cited by 43
DJ-1 Changes in G93A-SOD1 Transgenic Mice: Implications for Oxidative Stress in ALS
Lev, N., Ickowicz, D., Barhum, Y., Melamed, E., & Offen, D. (2008) · Journal of Molecular Neuroscience · doi:10.1007/s12031-008-9138-7 · Cited by 42
Towner, R. A., Smith, N., Saunders, D., Lupu, F., Silasi‐Mansat, R., West, M. S., Ramírez, D. C., Gomez-Mejiba, S., Bonini, M. G., Mason, R. P., et al. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.05.026 · Cited by 40
Veyrat‐Durebex, C., Bris, C., Codron, P., Bocca, C., Chupin, S., Corcia, P., Vourc’h, P., Hergesheimer, R. C., Cassereau, J., Funalot, B., et al. (2019) · Molecular Neurobiology · doi:10.1007/s12035-019-1484-7 · Cited by 41
Molecular Mechanisms Linking ALS/FTD and Psychiatric Disorders, the Potential Effects of Lithium
Limanaqi, F., Biagioni, F., Ryskalin, L., Busceti, C. L., & Fornai, F. (2019) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2019.00450 · Cited by 41
Halloran, M. A., Ragagnin, A., Vidal, M., Parakh, S., Yang, S., Heng, B., Grima, N., Shahheydari, H., Soo, K. Y., Blair, I. P., et al. (2019) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03394-w · Cited by 40
DJ-1 Knockout Augments Disease Severity and Shortens Survival in a Mouse Model of ALS
Lev, N., Barhum, Y., Lotan, I., Steiner, I., & Offen, D. (2015) · PLoS ONE · doi:10.1371/journal.pone.0117190 · Cited by 40
Kaus, A. S., & Sareen, D. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00448 · Cited by 42
Luan, W., Wright, A. L., Brown-Wright, H., Le, S., Gil, R. S., Martin, L. M. S., Ling, K., Jafar‐Nejad, P., Rigo, F., & Walker, A. K. (2023) · Molecular Psychiatry · doi:10.1038/s41380-023-02036-9 · Cited by 41
Stress granule formation helps to mitigate neurodegeneration
Glineburg, M. R., Yildirim, E., Gómez, N., Rodriguez, G., Pak, J., Li, X., Altheim, C. H., Waksmacki, J., McInerney, G. M., Barmada, S. J., et al. (2024) · Nucleic Acids Research · doi:10.1093/nar/gkae655 · Cited by 39
Wang, X., Ma, M., Teng, J., Che, X., Zhang, W., Feng, S., Zhou, S. Y., Zhang, Y., Wu, E., & Ding, X. (2015) · International Journal of Biological Sciences · doi:10.7150/ijbs.11880 · Cited by 42
Sharma, A., Varghese, A. M., Vijaylakshmi, K., Rajendrarao, S., Prasanna, V., Shanmukha, S., Sagar, B. K. C., Datta, K. K., Gowda, H., Nalini, A., et al. (2015) · Neurochemical Research · doi:10.1007/s11064-015-1779-7 · Cited by 38
Golomb, B. A., Verden, A., Messner, A. K., Koslik, H. J., & Hoffman, K. B. (2018) · Drug Safety · doi:10.1007/s40264-017-0620-4 · Cited by 38
Li, C., Chen, Y., Chen, X., Wei, Q., Ou, R., Gu, X., Cao, B., & Shang, H. (2020) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.15490 · Cited by 38
Understanding and managing metabolic dysfunction in Amyotrophic Lateral Sclerosis
Blasco, H., Lanznaster, D., Veyrat‐Durebex, C., Hergesheimer, R. C., Vourc’h, P., Maillot, F., Andres, C. R., Pradat, P., & Corcia, P. (2020) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2020.1788389 · Cited by 37
Interplay between TDP-43 and docosahexaenoic acid-related processes in amyotrophic lateral sclerosis
Cacabelos, D., Ayala, V., Granado‐Serrano, A. B., Jové, M., Torres, P., Boada, J., Cabré, R., Ramírez‐Núñez, O., Gonzalo‐Benito, H., Soler-Cantero, A., et al. (2016) · Neurobiology of Disease · doi:10.1016/j.nbd.2016.01.007 · Cited by 39
Self-citationSynaptic Failure: Focus in an Integrative View of ALS
Casas, C., Manzano, R., Vaz, A. R., Osta, R., & Brites, D. M. T. O. (2015) · Brain Plasticity · doi:10.3233/bpl-140001 · Cited by 39
Mori, A., Yamashita, S., Uchino, K., Suga, T., Ikeda, T., Takamatsu, K., Ishizaki, M., Koide, T., Kimura, E., Mita, S., et al. (2010) · Neurochemistry International · doi:10.1016/j.neuint.2010.12.010 · Cited by 35
Hicks, D. A., Cross, L. L., Williamson, R., & Rattray, M. (2019) · Neurochemical Research · doi:10.1007/s11064-019-02832-2 · Cited by 36
Protein clearing pathways in ALS.
Ferrucci, M., Fulceri, F., Toti, L., Soldani, P., Siciliano, G., Paparelli, A., & Fornai, F. (2011) · PubMed · doi:10.4449/aib.v149i1.1258 · Cited by 35
Lipid Metabolic Alterations in the ALS–FTD Spectrum of Disorders
Godoy-Corchuelo, J. M., Fernández-Beltrán, L. C., Ali, Z., Gil-Moreno, M. J., López-Carbonero, J. I., Guerrero-Sola, A., Larrad-Sainz, A., Matias-Guiu, J., Matias-Guiu, J. A., Cunningham, T. J., et al. (2022) · Biomedicines · doi:10.3390/biomedicines10051105 · Cited by 35
Melatonin Can Modulate Neurodegenerative Diseases by Regulating Endoplasmic Reticulum Stress
Yoo, Y., & Joo, S. S. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032381 · Cited by 35
A comprehensive serum lipidome profiling of amyotrophic lateral sclerosis
Fernández‐Eulate, G., Ruiz-Sanz, J. I., Riancho, J., Zufiría, M., Gereñu, G., Fernández‐Torrón, R., Aldea, J. J. P., Ondaro, J., Espinal, J. B., Chinchón, G. G., et al. (2020) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.1080/21678421.2020.1730904 · Cited by 37
Potential roles of the endoplasmic reticulum stress pathway in amyotrophic lateral sclerosis
Jeon, Y., Kwon, Y., Lee, S., & Kim, H. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1047897 · Cited by 34
Craig, R. A., de Vicente, J., Estrada, A. A., Feng, J. A., Lexa, K. W., Canet, M. J., Dowdle, W. E., Erickson, R. I., Flores, B. N., Haddick, P. C. G., et al. (2024) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.3c02422 · Cited by 31
Retinal Damage in Amyotrophic Lateral Sclerosis: Underlying Mechanisms
Soldatov, V. O., Kukharsky, M. S., Белых, А. Е., Sobolev, A., & Deykin, A. V. (2021) · Eye and Brain · doi:10.2147/eb.s299423 · Cited by 35
Marlin, E., Viu-Idocin, C., Arrasate, M., & Aragón, T. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23147823 · Cited by 32
Ito, Y., Shimazawa, M., Inokuchi, Y., Yamanaka, H., Tsuruma, K., Imamura, K., Onoe, H., Watanabe, Y., Aihara, M., Araie, M., et al. (2011) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2010.07578.x · Cited by 32
TDP-43 proteinopathy in ALS is triggered by loss of ASRGL1 and associated with HML-2 expression
Montojo, M. G., Fathi, S., Rastegar, C. T., Simula, E. R., Doucet-O’Hare, T. T., Cheng, Y.-H. H., Abrams, R. P. M., Pasternack, N., Malik, N., Bachani, M., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-48488-7 · Cited by 33
Suzuki, H., & Matsuoka, M. (2011) · Journal of Neuroscience Research · doi:10.1002/jnr.22777 · Cited by 31
Domínguez, M., de Oliveira, E., Odena, M. A., Portero‐Otín, M., Pamplona, R., & Ferrer, I. (2016) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2016.02.034 · Cited by 31
Self-citationZhao, C., Liao, Y., Rahaman, A., & Kumar, V. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.892518 · Cited by 32
Inappropriately chelated iron in the cerebrospinal fluid of amyotrophic lateral sclerosis patients
Ignjatović, A., Stević, Z., Lavrnić, D., Nikolić‐Kokić, A., Blagojević, D. P., Spasić, M. B., & Spasojević, I. (2012) · Amyotrophic Lateral Sclerosis · doi:10.3109/17482968.2012.665929 · Cited by 30
Palanivel, V., Gupta, V., Mirshahvaladi, S., Sharma, S., Gupta, V. B., Chitranshi, N., Mirzaei, M., Graham, S. L., & Basavarajappa, D. K. (2022) · Cells · doi:10.3390/cells11223665 · Cited by 31
Yang, Q., & Guo, Z. (2015) · International Journal of Neuroscience · doi:10.3109/00207454.2015.1050098 · Cited by 29
Effects of Mediterranean Diet Components on Neurodegenerative Diseases
Farooqui, A. A., & Farooqui, T. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-811959-4.00001-8 · Cited by 28
Keskin, I., Forsgren, E., Lange, D. J., Weber, M., Birve, A., Synofzik, M., Gilthorpe, J. D., Andersen, P. M., & Marklund, S. L. (2016) · PLoS ONE · doi:10.1371/journal.pone.0150133 · Cited by 29
Torres, P., Cacabelos, D., Pairada, J., Bauer, K. C., Boada, J., Fontdevila, L., Rossi, C., Povedano, M., Ferrer, I., Pamplona, R., et al. (2019) · Neurotherapeutics · doi:10.1007/s13311-019-00808-2 · Cited by 28
Self-citationLin, G., Mao, D., & Bellen, H. J. (2016) · Current topics in developmental biology/Current Topics in Developmental Biology · doi:10.1016/bs.ctdb.2016.07.004 · Cited by 29
Fine-Tuning ER Stress Signal Transducers to Treat Amyotrophic Lateral Sclerosis
Medinas, D. B., González, J. V., Falcón, P., & Hetz, C. A. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00216 · Cited by 27
Arima, H., Omura, T., Hayasaka, T., Masaki, N., Hanada, M., Xu, D., Banno, T., Kobayashi, K., Takeuchi, H., Kadomatsu, K., et al. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.03.060 · Cited by 27
TorsinA rescues ER-associated stress and locomotive defects in C. elegans models of ALS
Thompson, M. L., Chen, P., Yan, X., Kim, H., Borom, A. R., Roberts, N. B., Caldwell, K. A., & Caldwell, G. A. (2013) · Disease Models & Mechanisms · doi:10.1242/dmm.013615 · Cited by 27
Metadata
- Authors
- Ilieva, E. V., Ayala, V., Jove, M., Dalfo, E., Cacabelos, D., Povedano, M., Bellmunt, M. J., Ferrer, I., Pamplona, R., & Portero-Otin, M.
- Affiliations
- Universitat de Lleida (ES)
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2007-05-03
- Volume
- 130
- Issue
- 12
- Pages
- 3111-3123
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- OpenAlex
- W2105174553
- Cited by
- 358
- References
- 72
- Citations by year
- 2026: 12 · 2025: 12 · 2024: 21 · 2023: 15 · 2022: 17 · 2021: 14 · 2020: 17 · 2019: 20 · 2018: 13 · 2017: 23 · 2016: 15 · 2015: 26 · 2014: 23 · 2013: 21 · 2012: 28
- FWCI
- 13.37
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Brain (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Endoplasmic Reticulum Stress and Disease
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Genetic Neurodegenerative Diseases
- Keywords
- sporadic ALS, endoplasmic reticulum stress, oxidative stress, protein oxidation, protein disulfide isomerase, eIF2α phosphorylation, proteasome impairment, ubiquitin, docosahexaenoic acid, omega-3 fatty acids, mitochondrial dysfunction, respiratory chain complexes, frontal cortex, excitotoxicity, spinal cord
- MeSH terms
- Adult, Aged, Amyotrophic Lateral Sclerosis, Endoplasmic Reticulum, Fatty Acids, Female, Frontal Lobe, Humans, Male, Middle Aged, Mitochondria, Nerve Tissue Proteins, Organ Culture Techniques, Oxidation-Reduction, Spinal Cord, Oxidative Stress, Ubiquitin, Proteasome Endopeptidase Complex
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review